Items per page
Sort by

Send to:

Choose Destination

Results: 8

Cited In for PubMed (Select 18413835)


The future of vitamin D analogs.

Leyssens C, Verlinden L, Verstuyf A.

Front Physiol. 2014 Apr 3;5:122. doi: 10.3389/fphys.2014.00122. eCollection 2014. Review.


Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials.

Sperati F, Vici P, Maugeri-Saccà M, Stranges S, Santesso N, Mariani L, Giordano A, Sergi D, Pizzuti L, Di Lauro L, Montella M, Crispo A, Mottolese M, Barba M.

PLoS One. 2013 Jul 22;8(7):e69269. doi: 10.1371/journal.pone.0069269. Print 2013. Review.


Vitamin d: are we ready to supplement for breast cancer prevention and treatment?

Crew KD.

ISRN Oncol. 2013;2013:483687. doi: 10.1155/2013/483687. Epub 2013 Feb 26.


Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin.

Gee J, Bailey H, Kim K, Kolesar J, Havighurst T, Tutsch KD, See W, Cohen MB, Street N, Levan L, Jarrard D, Wilding G.

Prostate. 2013 Jun;73(9):970-8. doi: 10.1002/pros.22644. Epub 2013 Jan 17.


Phase I study of BIBF 1120 with docetaxel and prednisone in metastatic chemo-naive hormone-refractory prostate cancer patients.

Bousquet G, Alexandre J, Le Tourneau C, Goldwasser F, Faivre S, de Mont-Serrat H, Kaiser R, Misset JL, Raymond E.

Br J Cancer. 2011 Nov 22;105(11):1640-5. doi: 10.1038/bjc.2011.440. Epub 2011 Oct 25.


Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review.

Buttigliero C, Monagheddu C, Petroni P, Saini A, Dogliotti L, Ciccone G, Berruti A.

Oncologist. 2011;16(9):1215-27. doi: 10.1634/theoncologist.2011-0098. Epub 2011 Aug 11. Review.


Vitamin D metabolism and action in the prostate: implications for health and disease.

Swami S, Krishnan AV, Feldman D.

Mol Cell Endocrinol. 2011 Dec 5;347(1-2):61-9. doi: 10.1016/j.mce.2011.05.010. Epub 2011 Jun 1. Review.


Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy.

Trump DL, Deeb KK, Johnson CS.

Cancer J. 2010 Jan-Feb;16(1):1-9. doi: 10.1097/PPO.0b013e3181c51ee6. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk